Personal care compositions comprising dicocoyl pentaerythritol distearyl citrate
By incorporating dicocoyl pentaerythritol distearate citrate into sunscreen or daily care compositions, the toxicological and environmental problems of existing UV filters are resolved, achieving a combination of high SPF and good water resistance.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BASF SE
- Filing Date
- 2024-07-23
- Publication Date
- 2026-04-24
AI Technical Summary
Many UV filters in existing sunscreens are controversial due to toxicological or environmental reasons, making it difficult to develop compositions that have both high SPF and good water resistance.
Adding pentaerythritol distearate citrate to sunscreen or daily care compositions enhances the SPF and water resistance of organic UV filters.
It significantly improves the SPF value and water resistance of the composition, increasing the SPF by at least 10% and the water resistance by at least 20% compared to the composition without the wax.
Smart Images

Figure SMS_8 
Figure SMS_10 
Figure SMS_11
Abstract
Description
Technical Field
[0001] This invention relates to a sunscreen or daily care composition comprising: (i) disopyroxypentaerythritol distearate citrate; and (ii) at least one organic UV filter. Furthermore, this invention relates to the use of disopyroxypentaerythritol distearate citrate in improving the sun protection factor (SPF) and water resistance of sunscreen or daily care compositions comprising at least one organic UV filter, and the corresponding method of application. Background Technology
[0002] UV radiation has harmful effects on human skin. In addition to the acute effects of sunburn, UV radiation is known to increase the risk of skin cancer. Furthermore, prolonged exposure to UVA and UVB light can cause phototoxicity and photosensitivity reactions on the skin and may accelerate skin aging.
[0003] To protect human skin from UV radiation, various sunscreen UV filters (also known as UV absorbers) exist, including UVA filters, UVB filters, and broadband filters. Broadband filters are UV filters that absorb radiation within a wavelength range covering both UVA and UVB. All of these UV filters can be organic or inorganic, particulate or soluble compounds, and are widely used in sunscreens and everyday care compositions with UV protection.
[0004] However, while a wide variety of UV filters have been known and used in the past, many of these filters have become controversial in recent years due to toxicological or environmental reasons. Developing sunscreens that are free of these UV filters while maintaining a high SPF and other desired properties, such as water resistance, is challenging. In many cases, extensive reformulation is required, and efforts are underway to develop new sunscreen formulations that meet regulatory requirements while providing the same properties that consumers are accustomed to and expect.
[0005] Therefore, there is a need for novel personal care compositions that offer excellent SPF and good water resistance without requiring any of the organic UV filter substances currently facing toxicological or environmental concerns.
[0006] This invention addresses this need by providing a personal care composition that combines a high SPF value with excellent water resistance. Summary of the Invention
[0007] This invention is based on the following unexpected discovery by the inventors: by including a specific wax (i.e., disodium palmitoyl pentaerythritol distearate citrate) in personal care compositions, key properties of the formulation, particularly SPF and water resistance, are advantageously affected (i.e., increased). Particularly unexpectedly, disodium palmitoyl pentaerythritol distearate citrate, although it does not possess any sun protection effect on its own, significantly improves the SPF of the organic UV filter in which it is combined.
[0008] Therefore, in a first aspect, the present invention relates to a sunscreen or daily care composition comprising:
[0009] (i) Distearyl pentaerythritol distearate citrate; and
[0010] (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl dicamphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexyl butamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
[0011] In various embodiments, disocoacyl pentaerythritol distearate citrate is included in the composition in an amount of about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 2.0 to 5.0 wt.-%, based on the total weight of the composition.
[0012] In various embodiments, the composition comprises at least one UV filter in an amount of 1.5 to 40 wt.-% or 4.0 to 40.0 wt.-% based on the total weight of the composition, preferably 5.0 to 35.0 wt.-%, more preferably 6.0 to 35.0 wt.-% or 7.0 to 30.0 wt.-%, even more preferably 8.0 to 25.0 wt.-%, and particularly 9.0 to 20.0 wt.-%.
[0013] In various embodiments, at least one organic UV filter is selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
[0014] In various embodiments, the composition comprises at least one UVA filter, preferably selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), terephthalamide dicamphor sulfonic acid (TDSA), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof. Particularly preferred are: hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), terephthalamide dicamphor sulfonic acid (TDSA), and combinations thereof.
[0015] In various embodiments, the composition may comprise at least one UVB filter, preferably selected from the group consisting of ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenylbenzimidazole sulfonic acid (PBSA), polysiloxane-15 (PS-15), and combinations thereof. More preferably, it is selected from the group consisting of ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenylbenzimidazole sulfonic acid (PBSA), and combinations thereof.
[0016] In various embodiments, the composition comprises at least one broadband UV filter, preferably selected from the group consisting of: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), cresoltrazol trisiloxane (DTS), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), phenyl bis-diphenyltriazine (PBDT), and combinations thereof. Particularly preferred are: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), phenyl bis-diphenyltriazine (PBDT), and combinations thereof.
[0017] In various embodiments, the composition comprises at least one organic particulate UV filter selected from the group consisting of: methylene bis-benzotriazolyltetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), bis-(diethylaminohydroxybenzoylbenzoyl)piperazine (BDBP), phenyl bis-diphenyltriazine (PBDT), micronized 1,4-bis(benzoxazol-2'-yl)benzene, and combinations thereof. MBBT, TBPT, and combinations thereof are particularly preferred.
[0018] In some embodiments, the composition further comprises at least one inorganic UV filter, preferably selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, cerium oxide, and mixtures thereof.
[0019] In some embodiments, the composition comprises at least one UV filter selected from bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), diethylaminohydroxybenzoylhexylbenzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), butyl methoxydibenzoylmethane (BMDBM), terephthalic dimethylene camphor sulfonic acid (TDSA), and any combination of two or more thereof.
[0020] In some embodiments, the composition comprises bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and one or more of the following: diethylaminohydroxybenzoylhexyl benzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), butyl methoxydibenzoylmethane (BMDBM), and terephthalimide dicamphor sulfonic acid (TDSA).
[0021] In some embodiments, the composition comprises diethylaminohydroxybenzoylhexyl benzoate (DHHB) and one or more of the following: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), butyl methoxydibenzoylmethane (BMDBM), and terephthalic dimethylene camphor sulfonic acid (TDSA).
[0022] In some embodiments, the composition comprises ethylhexyl triazine (EHT) and one or more of the following: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), diethylaminohydroxybenzoylhexyl benzoate (DHHB), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), butyl methoxydibenzoylmethane (BMDBM), and terephthalic dimethylene camphor sulfonic acid (TDSA).
[0023] In some embodiments, the composition comprises butyl methoxydibenzoylmethane (BMDBM) and one or more of the following: diethylaminohydroxybenzoylhexyl benzoate (DHHB), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), and terephthalic dimethylene camphor sulfonic acid (TDSA).
[0024] In some embodiments, the composition comprises ethylhexyl triazine (EHT), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), and diethylaminohydroxybenzoylhexyl benzoate (DHHB), and optionally one of TBPT, PDSA, and TDSA.
[0025] In various embodiments, the composition comprises at least one broadband UV filter, preferably BEMT, preferably in an amount of 0.5 to 10.0 wt.-% based on the total weight of the composition, more preferably 2.0 to 5.0 wt.-%.
[0026] In various embodiments, the composition is free of at least one or more of fluorinated organic compounds and parabens.
[0027] In various embodiments, the composition is free of microplastics and compounds that generate such microplastics. The term generally includes compounds based on acrylates, polyamides, and vinylpyrrolidones, including but not limited to triacontyl PVP, VP / hexadecane copolymers, VP / eicosene copolymers, acrylate copolymers, sodium polyacrylate, and acrylate / acrylic acid C. 10-30 Alkyl ester crosspolymers, hydroxyethyl acrylate / sodium acryloyl dimethyl taurate copolymers, and acrylate / octylacrylamide copolymers.
[0028] In various embodiments, the composition does not contain ethylhexyl methoxycinnamate (EHMC). In various embodiments, the composition does not contain benzophenone-3 (BP-3). In various embodiments, the composition does not contain benzophenone-4 (BP-4). In various embodiments, the composition does not contain any one or more of ethylhexyl methoxycinnamate (EHMC), benzophenone-3 (BP-3), and benzophenone-4 (BP-4).
[0029] In various embodiments, the composition further comprises at least one additive, preferably selected from the group consisting of: emulsifiers, emollients, viscosity modifiers (thickeners), stabilizers, sensory enhancers, humectants, film-forming agents, UV scattering compounds, UV enhancers, pH adjusters, adjuvants, preservatives, vitamins, fragrances, and combinations thereof.
[0030] In another aspect, the present invention relates to the use of dicocoyl pentaerythritol distearate citrate for improving the sun protection factor and / or water resistance of sunscreen or daily care compositions comprising at least one UV filter.
[0031] In various embodiments of this use, the SPF is increased by at least 10%, at least 20%, and preferably at least 30% relative to the same composition which does not contain dicocoyl pentaerythritol distearate citrate.
[0032] In various embodiments of this application, the water resistance is increased by at least 20%, preferably at least 50%, compared to the same composition which does not contain pentaerythritol distearate citrate, but is optionally replaced by one containing hydrogenated coconut oil glyceride, hydrogenated castor oil or lauryl laurate.
[0033] In another aspect, the invention is also characterized by a method for improving the SPF and / or water resistance of a personal care composition by including dicocoyl pentaerythritol distearate citrate in such composition. Detailed Implementation
[0034] Before describing the preferred embodiments of the present invention in detail, definitions that are important for understanding the present invention are given.
[0035] As used in this specification and the appended claims, unless the context clearly indicates otherwise, the singular form “a / an” also includes the corresponding plural form.
[0036] In the context of this invention, the terms "about" and "approximately" indicate a range of precision that, as will be understood by those skilled in the art, still ensures the technical effect of the features discussed. These terms typically indicate a deviation from the indicated value of ±20%, preferably ±15%, more preferably ±10%, and even more preferably ±5%.
[0037] It should be understood that the term "comprising" is not limiting. For the purposes of this invention, the term "consisting of" is considered a preferred embodiment of the term "composed of". If a group is defined below as including at least a certain number of embodiments, this means that a group preferably consisting only of those embodiments is also covered.
[0038] Furthermore, the terms “first,” “second,” “third,” or “(i),” “(ii),” “(iii),” “(iv),” etc., used in the specification and claims are used to distinguish similar elements and are not necessarily used to describe a sequential or chronological order. It should be understood that such terms are interchangeable where appropriate, and the embodiments of the invention described herein can operate in orders other than those described or shown herein.
[0039] As used herein, the term "free from" in the context of the compositions of the invention being free from a specific compound or group of compounds (which may be grouped under a certain set of terms) means that the composition does not contain more than 0.2 wt.% of said compound or group of compounds based on the total weight of the composition. Furthermore, it is preferred that the compositions according to the invention do not contain more than 0.1 wt.% of said compound or group of compounds, and preferably the composition does not contain said compound or group of compounds at all. The same definition applies to the term "not containing". Furthermore, it should be understood that in the case where the composition does not contain compounds X and Y, the term "free from" or "not containing" means that the composition must be free from both compounds X and Y. In other words, the composition may not contain any compound selected from X and Y.
[0040] When referring to a composition and the weight percentage of its constituent components, it should be understood that, according to the invention, the total amount of the components does not exceed 100% (± 1%, due to rounding). If the given numerical value has no decimal places, the corresponding value includes the range resulting from normal rounding. For example, the value 10 thus includes the range of 9.5 to 10.4. This also applies if the number is given relative to the next decimal place. For example, the value 0.5 thus covers the range of 0.45 to 0.54.
[0041] It should be understood that the present invention is not limited to the specific methods, schemes, reagents, etc., described herein, as these can vary. It should also be understood that the terminology used herein is for the purpose of describing specific embodiments only and is not intended to limit the scope of the invention, which will be limited only by the appended claims. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.
[0042] The term "sunscreen composition" refers to any topical product that absorbs and can further reflect some portion of UV radiation. Therefore, the term "sunscreen composition" should be understood to include not only sunscreen compositions but also any cosmetic composition that provides UV protection. The term "topical product" refers to a product applied to the skin and can refer to, for example, sprays, lotions, creams, oils, gels, sticks, or foams. Sunscreen compositions may contain one or more active agents, such as organic or inorganic UV filters, as well as other ingredients or additives, such as emulsifiers, emollients, viscosity modifiers, stabilizers, humectants, film-forming agents, UV-scattering compounds, UV enhancers, pH adjusters, preservatives, moisturizers, anti-aging active ingredients, vitamins, or fragrances.
[0043] The sunscreen composition of the present invention can be formulated as a water-in-oil or oil-in-water dispersion, or an oil or oil-alcohol mixture, or a vesicle dispersion of ionic or nonionic amphiphilic lipids, or a gel, or a solid rod, or an aerosol formulation.
[0044] The term "daily care composition" refers to any topical product that absorbs and can further reflect and scatter UV radiation on certain parts of the body and is used as a daily care product for the human body (e.g., face or body). Daily care compositions may contain one or more active agents, such as organic and / or inorganic UV filters, as well as other ingredients or additives, such as emulsifiers, emollients, viscosity modifiers, stabilizers, humectants, film-forming agents, UV scattering compounds, UV enhancers, pH adjusters, preservatives, moisturizers, anti-aging active ingredients, vitamins, or fragrances.
[0045] According to the present invention, suitable daily care compositions are, for example, leave-on facial and body care products.
[0046] Suitable leave-on facial and body products include, for example, makeup preparations and skin care preparations.
[0047] Suitable makeup products include, for example, lipstick, nail polish, eyeshadow, mascara, dry and wet cosmetics, blush, powder, hair removal products, and sunscreen.
[0048] Suitable skin care preparations include, for example, moisturizing, improving, and lifting preparations. The listed daily care compositions may be in the form of creams, ointments, pastes, foams, gels, emulsions, powders, cosmetics, sprays, sticks, or aerosols.
[0049] As used herein, the term "discoyl pentaerythritol distearate citrate" is C40328-22-2 with CAS number 130328-22-2. 12-18The INCI name of a mixed ester of fatty acids, citric acid, pentaerythritol, and stearyl alcohol. The compound is commercially available, for example, from BASF SE under the trade name Cutina® Shine.
[0050] As used herein, the term "UV filter" refers to an organic or inorganic compound that can absorb or reflect UV radiation caused by sunlight. UV filters can be classified as UVA filters, UVB filters, or broadband filters based on their UV absorption protection curves. Preferably, the term "UV filter" includes any UV filter or a component thereof as defined in Annex VI of Regulation (EC) 1223 / 2009 of the European Parliament (version of November 11, 2022).
[0051] The definition of “broadband” protection (also known as broad-spectrum or wide-range protection) is based on, for example, a “critical wavelength.” For broadband coverage, both UVB and UVA protection must be provided. According to US and European requirements, a critical wavelength of at least 370 nm is needed to achieve broad-spectrum protection. Furthermore, in Europe, the European Commission recommends that all sunscreens should have a UVA protection factor that is at least one-third of the sun protection factor (SPF); for example, if a sunscreen composition has an SPF of 30, then the UVA protection factor must be at least 10.
[0052] The term "critical wavelength" is defined as a wavelength at which the area of the UV absorption spectrum (relative to the percentage of protection by absorption) accounts for 90% of the total area of the absorption spectrum in the UV region (290-400 nm). For example, a critical wavelength of 370 nm indicates that the protection of a sunscreen composition is not limited to the wavelength of UVB (i.e., the wavelength of 290-320 nm), but extends to 370 nm, such that 90% of the total area of the absorption spectrum in the UV region is reached at 370 nm.
[0053] As used herein, the term "Sun Protection Factor (SPF)" indicates the degree to which a sunscreen composition protects the skin from the appearance of erythema, primarily caused by UVB radiation. Specifically, this factor indicates how long protected skin can be exposed to sunlight without sunburn, compared to unprotected skin. For example, if a sunscreen composition with an SPF of 15 is used at 2 mg / cm²... 2 If applied evenly to the skin of someone who typically gets sunburned after 10 minutes in the sun, this sunscreen allows the person to stay in the sun for 15 times longer. In other words, SPF 15 means that 1 / 15 of the intense UV radiation will reach the skin, assuming a concentration of 2 mg / cm². 2 When the sunscreen is applied evenly in the correct dosage.
[0054] As used herein, “water resistance” refers to the property of a sunscreen product to remain on a surface after contact with water. “Water resistance” can be determined in vitro by spectroscopic measurements and can be based on the procedures described in Sohn et al., Int J Cosmet Sci, “In vitro water resistance testing using SPF simulation based on spectroscopic analysis of rinsed sunscreens”, 2018; DOI:10.1111 / ics.12455. The application of the sunscreen and the water immersion plus rinsing, along with the spectroscopic measurements, can be the same as described in Sohn et al. The sunscreen to be studied was applied at 2 mg / cm³. 2 An amount of the product was applied to a substrate plate made of ethylene methacrylate copolymer (described in Sohn et al., Skin Pharmacol Physiol, “Development of a Synthetic Substrate for the in vitro Performance Testing of Sunscreens”, 2017, 30:159-170). Two sunscreen-coated plates were then immersed in a water bath and kept in the dark at ambient temperature. Following immersion, each of the four plates (two water-immersed and two un-water-immersed) was rinsed with a solvent mixture of THF / ethanol / Neutrol® TE (from BASF Europe) (50:48:2) to recover the UV filter retained on the plates. The solvent / formulation solution was diluted (1:40) and filled into 1 cm quartz cuvettes for UV spectral measurements using a Lambda 20 apparatus in 5 nm increments from 290 to 400 nm. The results were obtained as transmittance data, converted to absorbance values, and the area under the curve (AUC) was calculated from these absorbance values. The AUC was then used to calculate the percentage water resistance (%WR). Unless otherwise indicated, the water resistance referred to herein has been determined according to the described method.
[0055] The “water-soluble UV filter” has a solubility in water of at least 2.0 wt.-%, preferably at least 3.0 wt.-%, more preferably at least 5.0 wt.-%.
[0056] "Oil-soluble UV filter" has the properties of being used in common cosmetic oils (such as benzoic acid C). 12 -C15 Solubility of at least 2.0 wt.-%, preferably at least 5.0 wt.-%, and more preferably at least 7.0 wt.-% in alkyl esters, dibutyl adipate, diisopropyl sebacate, phenethyl benzoate, or dioctyl carbonate.
[0057] The term "insoluble UV filter" refers to a UV filter that is insoluble in water and cosmetic oils at 25°C. These are also referred to herein as "particulate UV filters".
[0058] The inventors of this invention have unexpectedly discovered that the addition of a specific wax compound (i.e., disocoacyl pentaerythritol distearate citrate) enhances the sun protection factor and water resistance of personal care compositions containing UV filters not only relative to the same composition without this wax, but also relative to compositions containing other wax compounds (such as coconut oil glycerides, hydrogenated castor oil, or lauryl laurate).
[0059] Therefore, in a first aspect, the present invention provides a sunscreen or daily care composition comprising:
[0060] (i) Distearyl pentaerythritol distearate citrate; and
[0061] (ii) At least one organic UV filter.
[0062] Organic UV filters include triazine derivatives, triazole derivatives, benzotriazole derivatives, benzophenone derivatives, dibenzoylmethane derivatives, camphor derivatives, cinnamic acid esters, salicylic acid esters, benzimidazole sulfonic acid derivatives, silicone derivatives, para-aminobenzoic acid (PABA) derivatives, and combinations thereof.
[0063] Common examples of organic UV filters include, but are not limited to, ethylhexyl triazine ketone (EHT), dimethyl para-aminobenzoate (ED PABA), PEG-25 PABA, ethylhexyl salicylate (EHS), isoamyl methoxycinnamate (IMC), phenylbenzimidazole sulfonic acid (PBSA), 4-methylbenzyl camphor (4-MBC), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), cresoltrazolium trisiloxane (DTS), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), menthyl anthranilate (MA), diethylhexylbutamidotriazine ketone (DBT), benzyl malonic acid polysiloxane (BMP; polysiloxane-15; PS-15), disodium phenyl dibenzimidazole tetrasulfonate (DPDT), and homosalate. salicylate (HMS), diethylaminohydroxybenzoylhexyl benzoate (DHHB), triphenyltriazine (TBPT), 3,3'-(1,4-phenylene)bis(5,6-diphenyl-1,2,4-triazine) (PBDT), methoxypropylaminocyclohexeneylidene ethoxyethyl cyanoacetate (MCE), bis-(diethylaminohydroxybenzoylbenzoyl)piperazine (BDBP), and combinations thereof.
[0064] In various embodiments, at least one organic UV filter is selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
[0065] At least one organic UV filter may include a UVA filter. Suitable UVA filters may be selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (2-[4-(diethylamino)-2-hydroxybenzoyl]hexyl benzoate, DHHB), butyl methoxydibenzoylmethane (BMDBM, also known as avobenzone; 1-(4-(1,1-dimethylethyl)phenyl)-3-(4-methoxyphenyl)propane-1,3-dione), terephthalamide dicamphor sulfonic acid (TDSA), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
[0066] At least one organic UV filter may include a UVB filter. Suitable UVB filters may be selected from the group consisting of: ethylhexyl triazine ketone (EHT; 4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tri-benzoic acid-tris(2-ethylhexyl) ester), diethylhexylbutamidotriazine ketone (DBT; 4,4'-[[6-[[4-[[(1,1-dimethylethyl)amino]carbonyl]phenyl]amino]-1,3,5-triazine-2,4-diyl]diimino]bis-benzoic acid-bis(2-ethylhexyl) ester), phenylbenzimidazole sulfonic acid (PBSA), benzylmalonic acid polysiloxane (BMP; polysiloxane-15; PS-15), and combinations thereof.
[0067] At least one organic UV filter may include a broadband UV filter. Suitable broadband UV filters may be selected from the group consisting of: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), cresoltrazol trisiloxane (DTS; 2-(2H-benzotriazol-2-yl)-6-[(2-ethylhexyloxy)methyl]-4-methylphenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]-1-disiloxyl]propyl]phenol), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT; 2,2′-methylene bis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]), phenyl bis-diphenyltriazine (PBDT), and combinations thereof.
[0068] At least one organic UV filter may include an organic particulate UV filter, including the aforementioned UVA filter, UVB filter, and broadband UV filter in particulate form. Suitable organic particulate UV filters (i.e., insoluble solid organic UV filters) may be selected from the group consisting of: methylene bis-benzotriazolyltetramethylbutylphenol (MBBT; 2,2′-methylene bis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol]), tri-biphenyltriazine (TBPT; 2,4,6-tris(biphenyl-4-yl)-1,3,5-triazine), bis- (Diethylaminohydroxybenzoylbenzoyl)piperazine (BDBP; 1,1'-(1,4-piperazindiyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methyl ketone), phenylene bis-diphenyltriazine (PBDT; 5,6,5',6'-tetraphenyl-3-3'-(1,4-phenylene)bis(1,2,4-triazine)), 1,4-bis(benzoxazol-2'-yl)benzene, and combinations thereof. Further examples of suitable organic particulate UV filters are described, for example, in WO 9703643, WO 2009077356, and WO 2015155158. Preferably, the particulate UV filter has a particle size D of less than 2000 nm, preferably less than 1000 nm, more preferably less than 500 nm, as determined by light scattering. N 50, of which D N 50 refers to the particle size value, where half of the population is below this value and half is above this value; that is, the median of the particle size distribution.
[0069] The compositions of the present invention may additionally comprise inorganic UV filters. Suitable inorganic UV filters include, but are not limited to, titanium dioxide, zinc oxide, iron oxide, cerium oxide, and mixtures thereof. In various embodiments, the inorganic UV filters can be used as nanomaterials. In this regard, it should be understood that the term "nanomaterial" follows the definition in European Commission Recommendations (2011 / 696 / EU, 2022 / C229 / 01). Thus, in nanomaterials, based on a size distribution of quantity, 50% of the particles are less than 100 nm, which includes constituent particles present in aggregates or agglomerates. In another embodiment of the invention, the inorganic UV filters can be used as non-nanomaterials. Thus, in non-nanomaterials, based on a size distribution of quantity, more than 50% of the particles are greater than 100 nm. Mixtures of nano and non-nano inorganic UV filters can also be used. Furthermore, the inorganic UV filters can be coated or uncoated. If present, titanium dioxide is preferably coated, as uncoated titanium dioxide is photocatalytic and should be avoided in sunscreens. In the context of inorganic UV filters, suitable coatings can be organic and / or inorganic, and are disclosed, for example, in WO 2023 / 036749 A1.
[0070] In various embodiments, at least one organic UV filter is selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyltriazine (PBDT), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), polysiloxane-15 (PS-15), and combinations thereof. In some embodiments, the composition may comprise ethylhexyl salicylate.
[0071] In various preferred embodiments, at least one organic UV filter includes at least one, preferably at least two or at least three, selected from BEMT, EHT, BMDBM, DHHB, TBPT, PBSA, and TDSA. In various embodiments, the composition contains at least BEMT. In various embodiments, the composition contains at least DHHB. In various embodiments, the composition contains at least BMDBM. Dicocoyl pentaerythritol distearate citrate has been found to be particularly effective in increasing the SPF of compositions containing BEMT and / or BMDBM.
[0072] In various embodiments, the composition comprises at least one UVA filter, preferably selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
[0073] In various embodiments, the composition may contain at least one UVB filter, preferably selected from the group consisting of: ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenylbenzimidazole sulfonic acid (PBSA), polysiloxane-15 (PS-15), and combinations thereof.
[0074] In various embodiments, the composition comprises at least one broadband UV filter, preferably selected from the group consisting of: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), cresoltrazol trisiloxane (DTS), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), phenyl bis-diphenyltriazine (PBDT), and combinations thereof.
[0075] In various embodiments, the composition comprises at least one organic particulate UV filter selected from the group consisting of: methylene bis-benzotriazolyltetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), bis-(diethylaminohydroxybenzoylbenzoyl)piperazine (BDBP), phenyl bis-diphenyltriazine (PBDT), micronized 1,4-bis(benzoxazol-2'-yl)benzene, and combinations thereof.
[0076] In some embodiments, the composition further comprises at least one inorganic UV filter, preferably selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, cerium oxide, and mixtures thereof.
[0077] In some embodiments, the composition comprises at least one UV filter selected from bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), diethylaminohydroxybenzoylhexylbenzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), and any combination of two or more thereof.
[0078] In various embodiments, the composition comprises at least one UVA filter (such as DHHB or BMDBM) and at least one UVB filter (such as EHT or PBSA).
[0079] In various embodiments, the composition comprises at least one broadband UV filter (such as BEMT) and at least one UVA filter (such as DHHB or BMDBM).
[0080] In various embodiments, the composition comprises at least one broadband UV filter (such as BEMT) and at least one UVB filter (such as EHT or PBSA).
[0081] In various embodiments, the composition comprises at least one broadband UV filter (such as BEMT), at least one UVA filter (such as DHHB or BMDBM), and at least one UVB filter (such as EHT or PBSA).
[0082] In various embodiments, the composition comprises at least one particulate UV filter (such as MBBT or TBPT) and at least one UVA filter, UVB filter and / or broadband UV filter (such as any one or more of DHHB, BMDBM, EHT, PBSA and BEMT).
[0083] In various embodiments, the composition comprises at least one broadband UV filter, preferably BEMT. In all embodiments disclosed herein, BEMT may be provided as an oil-soluble UV filter, or encapsulated or dissolved in a polyacrylate matrix for dispersibility in water. In the latter case, it is available, for example, under the trade names Tinosorb® S Aqua or Tinosorb® SLite Aqua.
[0084] In some embodiments, the composition comprises (1) bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and (2) any one or more of the following: diethylaminohydroxybenzoylhexyl benzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), and phenylbenzimidazole sulfonic acid (PBSA).
[0085] Specifically, the composition may contain
[0086] (1) BEMT and DHHB;
[0087] (2) BEMT and EHT;
[0088] (3) BEMT and MBBT;
[0089] (4) BEMT and TBPT;
[0090] (5) BEMT and PBSA;
[0091] (6) BEMT and TDSA
[0092] (7) BEMT, DHHB and EHT;
[0093] (8) BEMT, DHHB, and MBBT,
[0094] (9) BEMT, DHHB and TBPT;
[0095] (10) BEMT, DHHB and PBSA;
[0096] (11) BEMT, DHHB and TDSA;
[0097] (12) BEMT, EHT and MBBT;
[0098] (13) BEMT、EHThéTBPT;
[0099] (14) BEMT、EHThéPBSA;
[0100] (15) BEMT、EHThéTDSA;
[0101] (16) BEMT, MBBT and TBPT;
[0102] (17) BEMT, MBBT and PBSA;
[0103] (18) BEMT, MBBT and TDSA;
[0104] (19) BEMT、TBPThéPBSA;
[0105] (20) BEMT、TBPThéTDSA;
[0106] (21) BEMT, DHHB, EHT and MBBT;
[0107] (22) BEMT、DHHB、EHThéTBPT、
[0108] (23) BEMT、DHHB、EHThéPBSA;
[0109] (24) BEMT、DHHB、EHThéTDSA;
[0110] (25) BEMT, EHT, MBBT and TBPT;
[0111] (26) BEMT, EHT, MBBT and PBSA;
[0112] (27) BEMT、EHT、MBBThéTDSA;
[0113] (28) BEMT, MBBT, TBPT and PBSA;
[0114] (29) BEMT, DHHB, EHT, MBBT and TBPT;
[0115] (30) BEMT, DHHB, EHT, MBBT and PBSA;
[0116] (31) BEMT, DHHB, EHT, MBBT and TDSA;
[0117] (32) BEMT、DHHB、EHT、TBPThéPBSA;
[0118] (33) BEMT, DHHB, MBBT, PBSA and TBPT;
[0119] (34) BEMT, EHT, MBBT, TBPT, and PBSA; or
[0120] (35)BEMT, DHHB, EHT, MBBT, TBPT and PBSA.
[0121] In addition to those mentioned above, the composition may also contain one or more other UV filters, such as ethylhexyl salicylate or BMDBM, for example, BMDBM. In various embodiments, the composition may therefore contain:
[0122] (1) BEMT and BMDBM;
[0123] (2) BEMT, BMDBM and DHHB;
[0124] (3) BEMT, BMDBM and EHT;
[0125] (4) BEMT, BMDBM and MBBT;
[0126] (5) BEMT, BMDBM and TBPT;
[0127] (6) BEMT, BMDBM and PBSA;
[0128] (7) BEMT, BMDBM and TDSA
[0129] (8) BEMT, DHHB, BMDBM and EHT;
[0130] (9)BEMT, DHHB, BMDBM and MBBT,
[0131] (10) BEMT, DHHB, BMDBM and TBPT;
[0132] (11) BEMT, DHHB, BMDBM and PBSA;
[0133] (12) BEMT, DHHB, BMDBM and TDSA;
[0134] (13) BEMT, EHT, BMDBM and MBBT;
[0135] (14) BEMT, EHT, BMDBM and TBPT;
[0136] (15) BEMT, EHT, BMDBM and PBSA;
[0137] (16) BEMT, EHT, BMDBM and TDSA;
[0138] (17) BEMT, MBBT, BMDBM and TBPT;
[0139] (18) BEMT, MBBT, BMDBM and PBSA;
[0140] (19) BEMT、TBPT、BMDBMhéPBSA;
[0141] (20) BEMT, DHHB, EHT, BMDBM and MBBT;
[0142] (21) BEMT、DHHB、EHT、BMDBMhéTBPT,
[0143] (22) BEMT、DHHB、EHT、BMDBMhéPBSA;
[0144] (23) BEMT、DHHB、EHT、BMDBMhéTDSA;
[0145] (24) BEMT, EHT, MBBT, BMDBM and TBPT;
[0146] (25) BEMT、EHT、MBBT、BMDBMhéPBSA;
[0147] (26) BEMT、EHT、MBBT、BMDBMhéTDSA;
[0148] (27) BEMT, MBBT, TBPT, BMDBM and PBSA;
[0149] (28) BEMT, DHHB, EHT, MBBT, BMDBM and TBPT;
[0150] (29) BEMT, DHHB, EHT, MBBT, BMDBM and PBSA;
[0151] (30) BEMT、DHHB、EHT、TBPT、BMDBMhéPBSA;
[0152] (31) BEMT, DHHB, MBBT, PBSA, BMDBM and TBPT;
[0153] (32) BEMT、EHT、MBBT、TBPT、BMDBMhéPBSA;huò
[0154] (33) BEMT, DHHB, EHT, MBBT, TBPT, BMDBM and PBSA.
[0155] In some embodiments, the composition comprises (1) diethylaminohydroxybenzoylhexyl benzoate (DHHB) and (2) any one or more of the following: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), terephthalimide dicamphor sulfonic acid (TDSA), and phenylbenzimidazole sulfonic acid (PBSA).
[0156] Specifically, the composition may contain
[0157] (1) DHHB and EHT;
[0158] (2) DHHB and MBBT;
[0159] (3) DHHB and TBPT;
[0160] (4) DHHB and PBSA;
[0161] (5) DHHB and TDSA
[0162] (6) DHHB, EHT and MBBT;
[0163] (7) DHHB, EHT and TBPT;
[0164] (8) DHHB, EHT and PBSA;
[0165] (9) DHHB, EHT and TDSA;
[0166] (10) DHHB, MBBT and TBPT;
[0167] (11) DHHB, MBBT and PBSA;
[0168] (12) DHHB, MBBT and TDSA;
[0169] (13) DHHB, TBPT and PBSA;
[0170] (14)DHHB, EHT, MBBT and TBPT;
[0171] (15)DHHB, EHT, MBBT and PBSA;
[0172] (16)DHHB, EHT, MBBT and TDSA;
[0173] (17)DHHB, MBBT, TBPT and PBSA;
[0174] (18) DHHB, MBBT, TBPT, and TDSA; or
[0175] (19)DHHB, EHT, MBBT, TBPT and PBSA.
[0176] In addition to those mentioned above, the composition may also contain one or more other UV filters, such as ethylhexyl salicylate or BMDBM, for example, BMDBM.
[0177] Specifically, the composition may contain
[0178] (1) DHHB and BMDBM;
[0179] (2) DHHB, BMDBM and EHT;
[0180] (3) DHHB, BMDBM and MBBT;
[0181] (4) DHHB, BMDBM and TBPT;
[0182] (5) DHHB, BMDBM and PBSA;
[0183] (6) DHHB, BMDBM and TDSA
[0184] (7) DHHB, EHT, BMDBM and MBBT;
[0185] (8) DHHB, EHT, BMDBM and TBPT;
[0186] (9) DHHB, EHT, BMDBM and PBSA;
[0187] (10) DHHB, EHT, BMDBM and TDSA;
[0188] (11) DHHB, MBBT, BMDBM and TBPT;
[0189] (12)DHHB, MBBT, BMDBM and PBSA;
[0190] (13) DHHB, TBPT, BMDBM and PBSA;
[0191] (14)DHHB, EHT, MBBT, BMDBM and TBPT;
[0192] (15)DHHB, EHT, MBBT, BMDBM and PBSA;
[0193] (16) DHHB, MBBT, TBPT, BMDBM, and PBSA; or
[0194] (17)DHHB, EHT, MBBT, TBPT, BMDBM and PBSA.
[0195] In some embodiments, the composition comprises (1) ethylhexyltriazine (EHT) and (2) any one or more of the following: bis-ethylhexyloxyphenol methoxyphenyltriazine (BEMT), diethylaminohydroxybenzoylhexylbenzoate (DHHB), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), terephthalimide dicamphor sulfonic acid (TDSA), and phenylbenzimidazole sulfonic acid (PBSA). In various embodiments, it may also comprise BMDBM.
[0196] Specifically, the composition may contain
[0197] (1) EHT and MBBT;
[0198] (2) EHT and TBPT;
[0199] (3) EHT and PBSA;
[0200] (4) EHT and TDSA;
[0201] (5) EHT, MBBT and TBPT;
[0202] (6) EHT, MBBT and PBSA;
[0203] (7) EHT, MBBT and TDSA;
[0204] (8) EHT, TBPT and PBSA;
[0205] (9) EHT, TBPT and TDSA;
[0206] (10)EHT, TDSA and PBSA;
[0207] (11)EHT, TBPT, TDSA and MBBT;
[0208] (12) EHT, TBPT, TDSA and PBSA;
[0209] (13)EHT, MBBT, TDSA and PBSA;
[0210] (14)EHT, MBBT, TDSA and TBPT;
[0211] (15) EHT, MBBT, TBPT, and PBSA; or
[0212] (16)EHT, MBBT, TDSA, TBPT and TDSA.
[0213] Specifically, the composition may contain
[0214] (1) EHT and BMDBM;
[0215] (2) BMDBM and MBBT;
[0216] (3) BMDBM and TBPT;
[0217] (4) BMDBM and PBSA;
[0218] (5) BMDBM and TDSA;
[0219] (6) EHT, BMDBM and TBPT;
[0220] (7) EHT, BMDBM and PBSA;
[0221] (8) EHT, MBBT, BMDBM and TBPT;
[0222] (9) EHT, MBBT, BMDBM and PBSA;
[0223] (10) EHT, TBPT, BMDBM, and PBSA; or
[0224] (11) EHT, MBBT, TBPT, BMDBM and PBSA.
[0225] In some embodiments, the composition comprises ethylhexyl triazine (EHT), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), and diethylaminohydroxybenzoylhexyl benzoate (DHHB).
[0226] In some embodiments, the composition comprises BEMT, EHT, DHHB, and TBPT.
[0227] In some embodiments, the composition comprises BEMT, EHT, DHHB, PBSA, and TBPT.
[0228] In some embodiments, the composition comprises BEMT, DHHB, EHT, and PBSA.
[0229] In some embodiments, the composition comprises BEMT, EHT, DHHB, and TDSA.
[0230] In all the embodiments listed above with different UV filter combinations, except for those explicitly listed, the composition may not contain other organic UV filters, or even other UV filter substances. This may mean that at least one organic UV filter consists of the combinations listed above.
[0231] In various embodiments in which the composition comprises BEMT, BEMT is contained in an amount of 0.5 to 10.0 wt.-%, preferably 1.0 to 6.0 wt.-%, more preferably 2.0 to 5.0 wt.-%, based on the total weight of the composition.
[0232] In various embodiments in which the composition comprises EHT, EHT is contained in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition.
[0233] In various embodiments in which the composition comprises PBSA, PBSA is contained in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition.
[0234] In various embodiments in which the composition comprises TDSA, the TDSA is contained in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition.
[0235] In various embodiments in which the composition comprises DHHB, DHHB is contained in an amount of 0.5 to 10.0 wt.-%, preferably 2.0 to 8.0 wt.-%, more preferably 4.0 to 7.0 wt.-%, based on the total weight of the composition.
[0236] In various embodiments in which the composition comprises TBPT, TBPT is contained in an amount of 0.5 to 10.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 2.0 to 4.0 wt.-%, based on the total weight of the composition.
[0237] In various embodiments in which the composition comprises BMDBM, BMDBM is included in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 2.0 to 5.0 wt.-%, based on the total weight of the composition.
[0238] In various embodiments in which the composition comprises MBBT, MBBT is included in an amount of 0.5 to 10.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 1.5 to 4.0 wt.-%, based on the total weight of the composition.
[0239] In various embodiments in which the composition comprises ethylhexyl salicylate, ethylhexyl salicylate is included in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 2.0 to 5.0 wt.-%, based on the total weight of the composition.
[0240] In various embodiments, the composition comprises at least one organic UV filter in an amount of 1.5 to 40 wt.-%, 2.0 to 40 wt.-%, 2.5 to 40 wt.-%, 3.0 to 40 wt.-%, 3.5 to 40 wt.-%, or 4.0 to 40.0 wt.-%, preferably 5.0 to 35.0 wt.-%, more preferably 6.0 to 35.0 wt.-%, or 7.0 to 30.0 wt.-%, even more preferably 8.0 to 25.0 wt.-%, and particularly 9.0 to 20.0 wt.-%, based on the total weight of the composition. These amounts may also apply to the total amount of all UV filters, including inorganic UV filters. In various embodiments, the sun protection or daily care composition comprises 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 wt.% of UV filter based on the total weight of the composition. The lower limit may be 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, or 6.0 wt.% based on the total weight of the composition. The upper limit may be 40.0, 35.0, 30.0, 29.0, 28.0, 27.0, 26.0, or 25.0 wt.% of UV filter based on the total weight of the composition.
[0241] In various embodiments, the weight ratio of at least one broadband UV filter to at least one UVB filter, at least one UVA filter, or at least one particulate UV filter may be in the range of 1:5 to 5:1, for example, 1:3 to 3:1.
[0242] In various embodiments, the weight ratio of at least one UVA filter to at least one UVB filter or at least one particulate UV filter can be in the range of 1:5 to 5:1, for example 1:3 to 3:1.
[0243] In various embodiments, the weight ratio of at least one UVB filter to at least one particulate UV filter can be in the range of 1:5 to 5:1, for example, 1:3 to 3:1.
[0244] In various embodiments, the weight ratio of at least one particulate UV filter to at least one UVB filter or at least one UVA filter may be in the range of 1:5 to 5:1, for example 1:3 to 3:1.
[0245] In various embodiments, disoprocoyl pentaerythritol distearate citrate is included in the composition in an amount of about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, based on the total weight of the composition. The lower limit of the amount included in the composition can be 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1.0 wt.-%. Typical amounts are, for example, about 1.5, 2.0, 2.5, 3.0, 3.5, or 4.0 wt.-%.
[0246] In various embodiments, the weight ratio between the total amount of organic UV filter and distearyl pentaerythritol distearate citrate is typically 1:1 or greater, such as 2:1 to 20:1, typically in the range of 3:1 to 15:1, such as 4:1 to 12:1.
[0247] In various embodiments, the composition comprises at least one organic UV filter in an amount of 4.0 to 40.0 wt.-%, preferably 5.0 to 35.0 wt.-%, more preferably 6.0 to 35.0 wt.-%, or 7.0 to 30.0 wt.-%, even more preferably 8.0 to 25.0 wt.-%, and particularly 9.0 to 20.0 wt.-%, based on the total weight of the composition, and in an amount of about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, based on the total weight of the composition, dicocoyl pentaerythritol distearate citrate.
[0248] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, of the total weight of the composition and 0.5 to 10.0 wt.-%, preferably 1.0 to 6.0 wt.-%, more preferably 2.0 to 5.0 wt.-%, of the total weight of the composition. In various embodiments, the weight ratio of distearate to BEMT can be in the range of 0.4:1 to 1.2:1, preferably 0.5:1 to 1:1.
[0249] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, of the total weight of the composition and 0.5 to 10.0 wt.-%, preferably 2.0 to 8.0 wt.-%, more preferably 4.0 to 7.0 wt.-%, of the total weight of the composition. In various embodiments, the weight ratio of distearate to DHHB can be in the range of 0.2:1 to 1:1, preferably 0.3:1 to 0.8:1.
[0250] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, and EHT in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition. In various embodiments, the weight ratio of distearate to EHT can be in the range of 0.5:1 to 1.5:1, preferably 0.5:1 to 1:1.
[0251] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, based on the total weight of the composition, and 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition. In various embodiments, the weight ratio of distearate to PBSA can be in the range of 0.5:1 to 1.5:1, preferably 0.5:1 to 1:1.
[0252] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, of the total weight of the composition and 0.5 to 10.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 2.0 to 4.0 wt.-%, of the total weight of the composition. In various embodiments, the weight ratio of distearate to TBPT can be in the range of 0.2:1 to 1:1, preferably 0.4:1 to 1:1.
[0253] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, and TDSA in an amount of 0.5 to 5.0 wt.-%, preferably 1.0 to 4.0 wt.-%, more preferably 1.5 to 3.0 wt.-%, based on the total weight of the composition. In various embodiments, the weight ratio of distearate to TDSA can be in the range of 0.5:1 to 1.5:1, preferably 0.5:1 to 1:1.
[0254] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, of the total weight of the composition and 0.5 to 5.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 2.0 to 5.0 wt.-%, of the total weight of the composition. In various embodiments, the weight ratio of distearyl palmitate to BMDBM can be in the range of 0.2:1 to 1:1, preferably 0.4:1 to 1:1.
[0255] In various embodiments, the composition comprises about 0.5 to 8.0 wt.-%, preferably about 1.0 to 6.0 wt.-%, more preferably about 1.5 to 5.0 wt.-%, of the total weight of the composition and 0.5 to 10.0 wt.-%, preferably 1.0 to 5.0 wt.-%, more preferably 1.5 to 4.0 wt.-%, of the total weight of the composition. In various embodiments, the weight ratio of distearate to MBBT can be in the range of 0.5:1 to 1.5:1, preferably 0.5:1 to 1:1.
[0256] The above embodiments can be further combined such that the composition contains the given amount of disocoacyl pentaerythritol distearate citrate and two or more of the listed UV filters in the given amount for each of them.
[0257] In various embodiments, the composition does not contain octyl cyanobenzyl acrylate.
[0258] In various embodiments, the composition does not contain benzophenone-3.
[0259] In various embodiments, the composition does not contain ethylhexyl methoxycinnamate (EHMC) (also known as octyl methoxycinnamate). It has been found that EHMC has the least significant SPF enhancement compared to other organic UV filters tested.
[0260] In various embodiments, the composition is free of EHMC and benzophenone-3, and optionally also free of octyl cyanobenzyl acrylate.
[0261] In some embodiments, the composition is free of fluorinated organic compounds, parabens, and at least one or more organic UV filter compounds selected from the group consisting of homosalate, ethylhexyl methoxycinnamate, benzophenone-3, and octyl cyanadieneacrylate. In certain embodiments, the sunscreen or daily care composition is free of fluorinated organic compounds. In some embodiments, the sunscreen or daily care composition is free of parabens. In various embodiments, the sunscreen or daily care composition is free of homosalate. In various embodiments, the sunscreen or daily care composition is free of ethylhexyl methoxycinnamate. In various embodiments, the sunscreen or daily care composition is free of octyl cyanadieneacrylate. In various embodiments, the sunscreen or daily care composition is free of benzophenone-3. In various embodiments, the sunscreen or daily care composition is free of homosalate, ethylhexyl methoxycinnamate, octyl cyanadieneacrylate, and benzophenone-3. In various embodiments, the sunscreen or daily care composition is free of fluorinated organic compounds, parabens, and organic UV filter compounds selected from the group consisting of homosalate, ethylhexyl methoxycinnamate, octyl cyanobenzyl acrylate, and benzophenone-3.
[0262] In various embodiments, the sunscreen or daily care composition provides an SPF greater than 15, preferably greater than 30. In another preferred embodiment of the invention, the sunscreen or daily care composition provides an SPF greater than 50, preferably greater than 60. In yet another preferred embodiment of the invention, the sunscreen or daily care composition provides an SPF greater than 90, preferably greater than 100. SPF can be determined according to any method known in the art.
[0263] Furthermore, in conjunction with the above embodiments, it should be understood that sunscreen or daily care compositions may contain at least one additive other than disococoyl pentaerythritol distearate citrate.
[0264] In one embodiment, at least one additional additive is selected from the group consisting of: emulsifiers, emollients, viscosity modifiers (thickeners), stabilizers, humectants, film-forming agents, UV scattering compounds, UV enhancers, pH adjusters, sensory enhancers, adjuvants, preservatives, moisturizers, anti-aging active ingredients, vitamins, fragrances, and combinations thereof. All such additives commonly used in personal care compositions are well known and can be selected by those skilled in the art based on their conventional knowledge.
[0265] In various embodiments, the compositions of the present invention comprise at least one emulsifier. The at least one emulsifier may be selected from those disclosed below. In various embodiments, the amount of the at least one emulsifier relative to the total weight of the composition is in the range of 0.5 to 10 wt.-%, for example, 0.8 to 7 wt.-%.
[0266] In various embodiments, the compositions of the present invention comprise at least one emollient. The at least one emollient may be selected from those disclosed below. In various embodiments, the amount of the at least one emollient relative to the total weight of the composition is in the range of 0.5 to 40 wt.-%, for example, 3.0 to 30 wt.-%.
[0267] In various embodiments, the compositions of the present invention comprise at least one emulsifier and at least one emollient, preferably in the amounts disclosed above.
[0268] Preferred O / W emulsifiers include, but are not limited to,
[0269] - Glucose derivatives, such as cetyl glucoside, arachidonic glucoside, lauryl glucoside, polyglyceryl-3-methyl glucose distearate, and methyl sesquistearate glucose.
[0270] - Sucrose derivatives, such as sucrose polystearate and sucrose palmitate;
[0271] - Sorbitol derivatives, such as polysorbate derivatives;
[0272] Inulin derivatives, such as inulin lauryl carbamate;
[0273] - Glyceryl esters of fatty acids, such as glyceryl stearate, glyceryl stearate SE, glyceryl stearate citrate, and glyceryl oleate;
[0274] - Glutamic acid derivatives, such as sodium stearoyl glutamate;
[0275] - Sulfosuccinic acid derivatives, such as disodium cetearyl sulfosuccinate;
[0276] - Phosphoric acid derivatives, such as cetyl phosphate potassium, cetyl alcohol polyether-10 phosphate, and C20-22 alkyl phosphate;
[0277] - Polyglycerol-based fatty acid esters, such as polyglycerol-3-diisostearate, polyglycerol-2-dipolyhydroxystearate; polyglycerol-10-stearate, polyglycerol-10-oleate,
[0278] -Oxyolefinated fatty alcohols, such as cetearyl alcohol polyether-20, stearyl alcohol polyether-21, behenyl alcohol polyether-25
[0279] -Oxylenized fatty acids, such as PEG-100 stearate
[0280] -Oxylenized organic modified silicone / polysiloxane / polyalkyl / polyether copolymers and derivatives.
[0281] - Phospholipid-based, such as lecithin derivatives.
[0282] In various embodiments, the O / W emulsifier may be selected from any one or more of the following: disodium cetearyl sulfosuccinate, sodium stearoyl glutamate, potassium cetyl phosphate, polyglycerol-10 stearate, polyglycerol-10 oleate, cetearyl glucoside, lauryl glucoside, sucrose palmitate, glyceryl stearate SE, and glyceryl stearate citrate. The total amount of the at least one emulsifier in the composition may be in the range of 0.5 to 25 wt.-%, for example 0.8 to 20 wt.-%, relative to the total weight of the composition.
[0283] Preferred emulsifiers for forming W / O emulsions include, but are not limited to,
[0284] - Glycerides of fatty acids, such as glyceryl oleate and sorbitan laurate.
[0285] -Sorbitol esters, such as sorbitol oleate
[0286] - Polyglycerol-based fatty acid esters, such as polyglycerol-3-diisostearate, polyglycerol-2-dipolyhydroxystearate, and polyglycerol-4-isostearate.
[0287] -Oxyolefinated fatty alcohols, such as stearyl alcohol polyether-2
[0288] -Oxyolefinated fatty acids, such as PEG-30 dimerized hydroxystearate
[0289] - Organically modified siloxane / polysiloxane / polyalkyl / polyether copolymers and derivatives, such as cetyl polydimethylsiloxane copolyols, cetyl PEG / PPG-10 / 1 polydimethylsiloxane, and PEG-10 polydimethylsiloxane.
[0290] Suitable moisturizers include, but are not limited to,
[0291] -Esters of straight-chain or branched fatty acids with straight-chain or branched fatty alcohols, such as propyl heptyl octanoate, cocoyl octanoate, isopropyl myristate, ethylhexyl palmitate, and lauryl lactate.
[0292] -Esters of aromatic carboxylic acids with straight-chain or branched fatty alcohols, such as C12-C15-alkyl benzoates, ethylhexyl benzoate, and phenylethyl benzoate;
[0293] - Dicarboxylic acid esters with straight-chain or branched-chain alcohols, such as dibutyl adipate, dioctyl carbonate, and diisopropyl sebacate;
[0294] Esters of α-hydroxycarboxylic acids with straight-chain or branched fatty alcohols;
[0295] - Esters of straight-chain or branched fatty acids with polyols, such as butanediol dioctanoate / didecanoate;
[0296] - Monoglycerides, diglycerides, and triglycerides based on C6-C18 fatty acids, such as caprylic / capric triglycerides and cocoyl alcohol triglycerides;
[0297] -Gerbert alcohols, such as octyldodecanool;
[0298] - Hydrocarbons, such as hydrogenated polyisobutylene, mineral oil, squalene, and isohexadecane;
[0299] -Ethers, such as dioctyl ether;
[0300] - Silicone derivatives (organically modified polysiloxanes), such as dimethyl polysiloxane and cyclic silicones.
[0301] In various embodiments, the emollient may be selected from one or more of the following: propyl heptaethyl caprylate, cocoyl caprylate, isopropyl myristate, ethylhexyl palmitate, dibutyl adipate, dioctyl carbonate, lauryl lactate, propylene glycol dicaprylate / didecanoate, diisopropyl sebacate, dioctyl ether, and octyl dodecyl alcohol. The total amount of at least one emollient may be in the range of 0.5 to 40 wt.-%, for example, 3.0 to 30 wt.-%, relative to the total weight of the composition.
[0302] Preferred lipophilic thickeners include, but are not limited to,
[0303] - Fatty alcohols, such as cetyl alcohol, cetearyl alcohol, stearyl alcohol; betaine alcohol
[0304] - Fatty acids, such as stearic acid; palmitic acid
[0305] - Fatty acid esters, such as myristyl stearate, pentaerythritol distearate, and cetyl palmitate; tribehenin and dextrin palmitate.
[0306] - Waxes, such as beeswax, carnauba wax, microcrystalline wax, ceresin, and ozocerite; rice bran wax and sunflower wax.
[0307] - Hydrogenated vegetable oil, hydrogenated castor oil, hydrogenated vegetable glycerides
[0308] - Hydrogenated castor oil / sebacic acid copolymer
[0309] -Silica-based derivatives, such as silica and dimethylsilyldimethylsilica.
[0310] - Polyacrylates or homopolymers or polyacrylamides of network acrylic acid, such as carbomer, acrylate copolymers, acrylate / acrylic acid C10-C30-alkyl ester crosspolymers, acrylate / behenol polyether-25 methacrylate copolymers.
[0311] In various embodiments, the thickener may be selected from one or more of cetyl alcohol, betaine alcohol, cetyl palmitate, carnauba wax, and pentaerythritol distearate.
[0312] Hydrophilic stabilizers / thickeners include, but are not limited to,
[0313] -Natural gums, such as xanthan gum, tara gum, carrageenan gum
[0314] - Silicate derivatives, such as magnesium aluminum silicate;
[0315] - Cellulose derivatives, such as hydroxypropyl cellulose and microcrystalline cellulose
[0316] - Starch derivatives, such as hydroxypropyl starch phosphate
[0317] - Polyacrylates or homopolymers or polyacrylamides of network acrylic acid, such as carbomer, acrylate copolymers, acrylate / acrylic acid C10-C30-alkyl ester crosspolymers, acrylate / behenol polyether-25 methacrylate copolymers.
[0318] It may also contain UV-protective scattering compounds. These include, but are not limited to:
[0319] - Microcrystalline cellulose;
[0320] -Calcium carbonate;
[0321] 2-hydroxyapatite;
[0322] -Silica
[0323] - Hollow spheres, such as styrene / acrylate copolymers.
[0324] It may also contain UV protection enhancing compound (UV enhancer). These include, but are not limited to:
[0325] -Benztriazolyldodecyl p-cresol
[0326] -Ethylhexylmethoxypolyacrylonitrile,
[0327] -Polyester-8,
[0328] - Diethylhexyl syringite
[0329] -Trimethoxybenzylpentanedione
[0330] Diethylhexyl 2,6-naphthalenedicarboxylate
[0331] -Bis(cyanoethyl butyl ester) 10-anthracene diene adipyl,
[0332] -Polyester-25,
[0333] - Butyl octyl salicylate.
[0334] Other components may fall into the categories of film-forming agents and film-forming enhancers. These compounds include, but are not limited to,
[0335] - Hydrogenated dimerized dilinoleyl / dimethyl carbonate copolymer;
[0336] -Diisostearoyl polyglycerol-3-dimeric dilinoleate;
[0337] - Polyglycerol-3-stearate / sebacate crosspolymer;
[0338] - Cellulose derivatives, such as methylcellulose and ethylcellulose;
[0339] -Octaylglycerol / Sebacic acid copolymer.
[0340] Suitable sensory enhancers include, but are not limited to,
[0341] - Polyamide derivatives, such as nylon-12,
[0342] - Polymethyl methacrylate,
[0343] -Silica,
[0344] -Mica,
[0345] - Polymethylsilsesquioxane,
[0346] - Starch derivatives, such as aluminum starch octenyl succinate.
[0347] - Polydimethylsiloxane derivatives
[0348] -boron nitride,
[0349] -HDI / trimethylolhexyl lactone crosslinking polymer
[0350] - Perlite.
[0351] Suitable wetting agents include, but are not limited to,
[0352] -glycerin;
[0353] -Butanediol;
[0354] -Propylene glycol;
[0355] -β-glucan;
[0356] -1,2-pentanediol;
[0357] -1,2-hexanediol;
[0358] -1,2-octanediol;
[0359] -1,2-decanediol;
[0360] -2-Methyl-1,3-propanediol.
[0361] Suitable adjuvants include, but are not limited to,
[0362] - Ethanol,
[0363] -dye,
[0364] - Pigments, such as iron oxide,
[0365] -Tocopherol derivatives;
[0366] -Retinol derivatives;
[0367] -Ascorbic acid derivatives;
[0368] -Biospermyl alcohol;
[0369] -Allantoin;
[0370] -Panthenol;
[0371] - Chelating agents (EDTA, EDDS, EGTA, phytic acid, piroctone olamine);
[0372] -Ethylhexylglycerol;
[0373] -Hydroxyacetophenone;
[0374] - Caprylhydroxymic acid.
[0375] - Propellants, such as propane, butane, isobutylene, and dimethyl ether;
[0376] - Insect repellents, such as butyl acetyl aminopropionate.
[0377] Preferred preservatives include compounds listed in Annex V of Regulation 1223 / 2009 / EC concerning cosmetic products, particularly, but not limited to,
[0378] -Benzyl alcohol;
[0379] -benzoic acid;
[0380] - Gingerone.
[0381] Suitable fragrances are selected from the group consisting of the following fragrance compounds, including but not limited to: limonene, citral, linalool, α-isomethylionone, geraniol, citronellol, 2-isobutyl-4-hydroxy-4-methyltetrahydropyran, 2-tert-butyl-pentylcyclohexyl acetate, 3-methyl-5-phenyl-1-pentanol, 7-acetyl-1,1,3,4,4,6-hexamethyltetrahydronaphthalene, adipate, α-pentanol, etc. Cinnamaldehyde, α-methyl ionone, pentyl-C-butylphenyl methylpropionaldehyde, cinnamaldehyde, amyl salicylate, pentyl cinnamyl alcohol, anisyl alcohol, benzoin, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, bergamot oil, bitter orange oil, butylphenyl methylpropionaldehyde, cardamom oil, cedrol, cinnamaldehyde, cinnamyl alcohol, citronellol crotonate, lemon oil, coumarin, diethyl succinate, ethyl linalool, eugenol, evernia extracts of *Furfuracea*, extracts of *Evernia prunastri*, farnesol, guaiac oil, hexylcinnamaldehyde, hexyl salicylate, hydroxycitronellol, lavender oil, lemon oil, linaylacetate, citrus oil, peppermint PCA, methyl heptenone, nutmeg oil, rosemary oil, sweet orange oil, terpineol, coumarin oil, triethyl citrate, vanillin, and combinations thereof.
[0382] In conjunction with the above preferred embodiments, it should be understood that if the sunscreen or daily care composition contains two or more additives, then the combination of additives as defined above is also part of the present invention.
[0383] The listed final formulations may be available in a variety of forms, such as: as liquids (sprays or emulsions) or creams, as water-in-oil (W / O), oil-in-water (O / W), water-in-oil-in-oil (O / W / O), water-in-oil-in-water (W / O / W), or phase inversion temperature (PIT) emulsions and various microemulsions; as gels; as oils; as powders, paints, tablets, or cosmetics; as sticks; as sprays (sprays with propellant gas or pump-operated sprays) or aerosols; as foams; or as pastes.
[0384] Therefore, in some embodiments, the sunscreen or daily care composition of the present invention comprises water. Where water is present in the sunscreen or daily care composition, it is preferably present in an amount exceeding 5 wt.% based on the total weight of the composition. Typical amounts of water in formulations range from 10 to 80 wt.% relative to the total weight of the composition, such as 20 to 70 wt.% or 30 to 60 wt.% or 35 to 55 wt.% water.
[0385] For example, when formulated as a W / O or O / W dispersion, the optional cosmetically acceptable carrier preferably comprises 5.0% to 50.0% of an oil phase, 1.0% to 10.0% of an emulsifier, and 30.0% to 90.0% of water, each by weight based on the total weight of the carrier. The oil phase may contain any lipophilic compound conventionally used in cosmetic formulations, such as one or more of hydrocarbon oils, waxes, natural oils, silicone oils, fatty acids, fatty acid esters, or fatty alcohols. Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexanediol, glycerin, and sorbitol. The emulsifier may also include any emulsifier conventionally used in cosmetic formulations, such as those described above.
[0386] In various embodiments, the sun protection or daily care composition of the present invention comprises:
[0387] (i) a amount of 0.5 to 8.0 wt.% of the total weight of the composition, comprising pentaerythritol distearate citrate;
[0388] (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexenelide ethoxyethyl cyanoacetate (MCE), and combinations thereof, in an amount of 4.0 to 40.0 wt.-% based on the total weight of the composition.
[0389] (iii) Optionally, at least one emulsifier, preferably in an amount of 0.5 to 10 wt.-% relative to the total weight of the composition, for example, 0.8 to 8 wt.-%.
[0390] (iv) Optionally, at least one emollient, preferably in an amount of 0.5 to 40 wt.-%, for example 3.0 to 30 wt.-%, relative to the total weight of the composition; and
[0391] (v) Water, preferably in an amount of 5 to 90 wt.-%, more preferably 10 to 80 wt.-%, even more preferably 20 to 70 wt.-%, 30 to 60 wt.-%, or 35 to 55 wt.-% relative to the total weight of the composition.
[0392] In various embodiments, the sun protection or daily care composition of the present invention comprises:
[0393] (i) a amount of 0.5 to 8.0 wt.% of the total weight of the composition, comprising pentaerythritol distearate citrate;
[0394] (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexenelide ethoxyethyl cyanoacetate (MCE), and combinations thereof, in an amount of 4.0 to 40.0 wt.-% based on the total weight of the composition.
[0395] (iii) at least one emulsifier, preferably in an amount of 0.5 to 10 wt.-%, for example 0.8 to 8 wt.-%, relative to the total weight of the composition, and / or at least one emollient, preferably in an amount of 0.5 to 40 wt.-%, for example 3.0 to 30 wt.-%, relative to the total weight of the composition; and
[0396] (iv) Water, preferably in an amount of 5 to 90 wt.-%, more preferably 10 to 80 wt.-%, or even more preferably 20 to 70 wt.-%, 30 to 60 wt.-%, or 35 to 55 wt.-% relative to the total weight of the composition.
[0397] In various embodiments, the sun protection or daily care composition of the present invention comprises:
[0398] (i) a amount of 0.5 to 8.0 wt.% of the total weight of the composition, comprising pentaerythritol distearate citrate;
[0399] (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexenelide ethoxyethyl cyanoacetate (MCE), and combinations thereof, in an amount of 4.0 to 40.0 wt.-% based on the total weight of the composition.
[0400] (iii) at least one emulsifier, preferably in an amount of 0.5 to 10 wt.-% relative to the total weight of the composition, for example 0.8 to 8 wt.-%.
[0401] (iv) at least one emollient, preferably in an amount of 0.5 to 40 wt.-% relative to the total weight of the composition, for example 3.0 to 30 wt.-%; and
[0402] (v) Water, preferably in an amount of 5 to 90 wt.-%, more preferably 10 to 80 wt.-%, even more preferably 20 to 70 wt.-%, 30 to 60 wt.-%, or 35 to 55 wt.-% relative to the total weight of the composition.
[0403] In various embodiments, the sun protection or daily care composition of the present invention comprises:
[0404] (i) a amount of 0.5 to 8.0 wt.% of the total weight of the composition, comprising pentaerythritol distearate citrate;
[0405] (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), terephthalamide dicamphor sulfonic acid (TDSA), ethylhexyl triazine (EHT), diethylhexylbutamidotriazine (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazine... The total amount of the following ingredients is 4.0 to 40.0 wt.-% based on the total weight of the composition: ozoletyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), cresoltrazol trisiloxane (DTS), phenylene bis-diphenyltriazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexeneylethoxyethyl cyanoacetate (MCE), and combinations thereof, preferably at least one of BEMT, EHT, BMDBM, DHHB, TBPT, PBSA, and TDSA, more preferably at least two or at least three.
[0406] (iii) At least one emulsifier selected from one or more of the following: sodium stearoyl glutamate, potassium cetyl phosphate, polyglycerol-10 stearate, polyglycerol-10 oleate, disodium cetearyl sulfosuccinate, cetearyl glucoside, lauryl glucoside, sucrose palmitate, glyceryl stearate SE, glyceryl stearate citrate, preferably in an amount of 0.5 to 10 wt.-%, for example 0.8 to 8 wt.-%, relative to the total weight of the composition.
[0407] (iv) At least one emollient selected from one or more of the following: propyl heptaethyl caprylate, cocoyl caprylate, isopropyl myristate, ethylhexyl palmitate, dibutyl adipate, dioctyl carbonate, diisopropyl sebacate, lauryl lactate, propylene glycol dioctyl ester / didecanoate, dioctyl ether, and octyl dodecyl alcohol, preferably in an amount of 0.5 to 40 wt.-%, for example 3.0 to 30 wt.-%, relative to the total weight of the composition; and
[0408] Water, preferably in an amount of 5 to 90 wt.-%, more preferably 10 to 80 wt.-%, even more preferably 20 to 70 wt.-%, 30 to 60 wt.-%, or 35 to 55 wt.-% relative to the total weight of the composition.
[0409] The sunscreen and / or day care compositions of the present invention can be formulated as water-in-oil or oil-in-water emulsions, oil or oil-alcohol compositions, gels, lipophilic monophases, or aerosol formulations. They can be, for example, in the form of creams, emulsions, gels, wax / fat compositions, solid lipophilic stick formulations, lipophilic monophases (liquid or gel), powders, or ointments. The sunscreen and / or day care compositions of the present invention can generally contain additives known to function usefully in sunscreen and / or day care compositions. Examples of such additives have been described above and include, for example, emollients, skin moisturizers (such as glycerin), skin tanning agents, antioxidants, emulsion stabilizers and thickeners (such as natural gums), fatty alcohols, fatty acid esters, film-forming agents, vitamins, preservatives, fragrances, and colorants.
[0410] Daily care compositions include facial and body preparations; facial cosmetic care products, such as foundation in cream, liquid, or powder form, and powder (loose or pressed); eye care products, such as eyeshadow preparations, mascara, eyeliner gel, eye cream, or eye repair cream; lip care products, such as lipstick, lip gloss, and lip liner; foot care products, such as foot baths, foot powder, foot cream, or foot ointment, specialized deodorants and antiperspirants, or callus removers; pre-tanning or after-sun preparations; skin tanning preparations, such as self-tanning creams; depigmenting preparations, such as preparations for bleaching skin or skin whitening preparations; and insect repellents, such as insect repellent oils, emulsions, sprays, or sticks.
[0411] Based on the above embodiments, it should be understood that sunscreen or daily care compositions are particularly suitable for protecting the skin from UV radiation.
[0412] Therefore, the present invention further relates to sunscreen or daily care compositions as defined herein for use in protecting human skin from UV radiation. The present invention further relates to a method of protecting human skin from UV radiation by topical application of a sunscreen or daily care composition as defined herein.
[0413] The present invention also relates to the use of disopyroxypentaerythritol distearate citrate for improving the sun protection factor (SPF) and / or water resistance of sunscreen or daily care compositions comprising at least one UV filter. In a preferred embodiment, it relates to the use of disopyroxypentaerythritol distearate citrate for improving the sun protection factor (SPF) of sunscreen or daily care compositions comprising at least one organic UV filter.
[0414] The "increase" in SPF can be relative to the same composition without pentaerythritol distearate citrate, and can be at least 10%, preferably at least 20%, more preferably at least 30%. In a preferred embodiment, the increase in SPF can refer to an increase in SPF relative to another composition without pentaerythritol distearate citrate or relative to a composition that instead contains another wax (such as hydrogenated coconut oil glyceride, hydrogenated castor oil, or lauryl laurate).
[0415] In various embodiments, the increase in water resistance may also be relative to the same composition comprising hydrogenated coconut oil glyceride, hydrogenated castor oil, or lauryl laurate (rather than distearyl pentaerythritol distearate citrate). Similarly, the increase may be at least 10%, at least 20%, at least 30%, at least 40%, preferably at least 50%, more preferably at least 60%, or at least 70%.
[0416] The present invention also relates to a method for increasing the water resistance or sun protection factor, particularly SPF, of a personal care composition containing at least one organic UV filter (such as those defined above) by incorporating disodium palmitate distearate into the composition.
[0417] This incorporation can be carried out by any suitable means, all of which are known to those skilled in the art.
[0418] It should be understood that the above examples of sunscreen or daily care compositions are also applicable to the uses and methods of the present invention, and vice versa.
[0419] The present invention is further illustrated by the following non-limiting examples. Example
[0420] method
[0421] Water-resistant in vitro solution method
[0422] In vitro water resistance was determined by spectroscopic measurements, based on the findings of Sohn et al., Int J Cosmet Sci, “In vitro water resistance testing using SPF simulation basedon spectroscopic analysis of rinsed sunscreens”, 2018; DOI:10.1111 / ics.12455. The steps of sunscreen application and water immersion, plus rinsing and spectroscopic measurements, were the same as described in Sohn et al.
[0423] Sunscreen application:
[0424] The sunscreen agent under investigation was applied to a 5 cm × 5 cm substrate plate made of ethylene methacrylate copolymer (described in Sohn et al., Skin Pharmacol Physiol, “Development of a Synthetic Substrate for the in vitro Performance Testing of Sunscreens”, 2017, 30:159-170; DOI:10.1159 / 000464471). These conditions should be understood as the most appropriate method currently available for determining the in vitro water resistance of formulations.
[0425] Apply 2 mg / cm to each plate 2 The dosage (corresponding to 50 mg of formulation per plate). A total of four plates were prepared for each sunscreen agent. After the sunscreen agent was applied, followed by a 15-minute equilibration period, two of the four plates were immersed in a water bath and the remaining two plates were kept in the dark at ambient temperature.
[0426] Water immersion conditions
[0427] Using a strip system from Tesa Hook & Loop tape, attach a sunscreen-coated plate to the rim of a 1000-mL beaker (10 cm in diameter) at a defined height. Fill the beaker with 500 mL of distilled water and maintain the temperature at 30°C ± 2°C. Stir the water at 300 rpm for 20 min using a three-bladed impeller equidistant from the attached plate. Then, remove the plate from the empty beaker and allow it to dry at ambient temperature for 30 min before proceeding.
[0428] Spectroscopic measurement and determination of water resistance value
[0429] Following impregnation, each of the four plates (two water-impregnated and two un-water-impregnated) was placed in a separate beaker and washed with 20 mL of a solvent mixture consisting of THF / ethanol / Neutrol® TE (from BASF Europe) (50:48:2). To collect the sunscreen from the plates, each plate was rinsed 10 times with a Pasteur pipette using the same solvent, and the plates were removed from the solvent with tweezers to visually remove all sunscreen residue from the substrate plates. The solvent / formulation solution was diluted (1:40) and filled into 1-cm quartz cuvettes for UV spectral measurements from 290 to 400 nm using a Lambda 20 apparatus in 5 nm steps. Water resistance retention was inferred from the UV transmittance measurements of the corresponding sunscreen solutions obtained from washing the water-impregnated and un-water-impregnated substrate plates. The transmittance data were then converted to absorbance data according to Equation 2:
[0430] A(λ) = -logT(λ)Eq(2)
[0431] Where A(λ) is absorbance and T(λ) is transmittance at wavelength λ.
[0432] Calculated from absorbance data after water immersion ( ) and not soaked in water ( The area under the curve (AUC) of the two plates is used to calculate the percentage of water resistance (%WR).
[0433] Due to the use of different plates to determine and Therefore, %WR is calculated as the ratio between the wetted average and the static average, as described in Equation 3 below:
[0434] .100, Eq(3)
[0435] in It is the average area under the absorbance curves of two plates that have been immersed in water, and It is the average area under the absorbance curves of two plates that have not been soaked in water (dry state).
[0436] In vitro SPF
[0437] In vitro SPF determination is based on the assessment of the UV transmittance of a film of sunscreen sample spread on a rough PMMA plate (SB6 PMMA plate from Creil Helioscreen, France). The sunscreen formulation to be tested was prepared at 1.2 mg / cm². 2Apply the formulation to a PMMA plate. Manually dispense the formulation as evenly as possible onto the plate. Then, before measurement, store the plate with the formulation applied at room temperature (22°C) and in the dark for 30 minutes.
[0438] In vitro transmittance measurements were performed using a Labsphere UV 2000S UV transmittance analyzer from 290 to 400 nm in 1 nm increments. UV transmittance spectra were then acquired, and in vitro SPF (average SPF of all 15 values from three plates, with 5 measurements per plate) was calculated according to the following equation.
[0439]
[0440] in, S(λ) is the erythema spectrum, S(λ) is the spectral irradiance received from the UV source, and T(λ) is the transmittance measured in vitro.
[0441] SPF in body
[0442] In vivo SPF is measured according to standard ISO 24444:2019, which utilizes the skin's erythema response to ultraviolet radiation. In vivo SPF is the ratio of energy required to induce a minimal erythema response when the tested sunscreen product is applied to the skin of a human test subject, with or without application.
[0443] In vivo water resistance
[0444] In vivo water resistance was evaluated by measuring the in vivo SPF (ISO 24444:2019) before and after water immersion, in accordance with standards ISO 16217:2020 and ISO 18861:2020.
[0445] Example 1
[0446] Table 1.1: Test Preparations
[0447]
[0448] Comparison = Comparison Examples / References
[0449] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. The mixture was then cooled to room temperature with stirring, and phase C was added.
[0450] The water resistance of all four formulations was tested in vitro. The results are shown in Table 1.2 below:
[0451] Table 1.2
[0452]
[0453] The results show that, compared with the same composition that does not contain the wax compounds of the present invention (Comparative 1.1) or those compositions that have other known wax compounds (Comparative 1.2 and Comparative 1.3), the formulation of the present invention 1 has significantly increased water resistance.
[0454] Example 2
[0455] Table 2.1: Test Preparations
[0456]
[0457] Comparison = Comparison Examples / References
[0458] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Pre-mixed phase C was added. The mixture was cooled to room temperature with stirring, and phase D was added.
[0459] The water resistance and SPF of all four formulations were tested in vitro. The results are shown in Table 2.2 below:
[0460] Table 2.2
[0461]
[0462] The results showed that the formulations of the present invention (2.1 and 2.2) had significantly increased water resistance and SPF compared to the same composition (Comparative 2.1) which did not contain the wax compounds of the present invention or those compositions which contained other known wax compounds (Comparative 2.2).
[0463] Example 3
[0464] Table 3.1: Test Preparations
[0465]
[0466] Comparison = Comparison Examples / References
[0467] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Premixed phase C was added, and the mixture was cooled to room temperature with stirring. Phase D was then added.
[0468] The water resistance and SPF of the two formulations were tested in vitro. The results are shown in Table 3.2 below:
[0469] Table 3.2
[0470]
[0471] The results showed that, compared with the same composition (Comparative 3) without the wax compounds of the present invention, the formulation of the present invention (the present invention 3) had significantly increased water resistance and SPF.
[0472] Example 4
[0473] Table 4.1: Test Preparations
[0474]
[0475] Comparison = Comparison Examples / References
[0476] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Pre-mixed phase C was added, and the mixture was cooled to room temperature with stirring.
[0477] The SPF of the two formulations were tested in vitro. The results are shown in Table 4.2 below:
[0478] Table 4.2
[0479]
[0480] The results showed that the formulation of the present invention (the present invention 4) had a significantly increased SPF compared to the same composition (Comparative 4) which did not contain the wax compounds of the present invention.
[0481] Example 5
[0482] Table 5.1: Test Preparations
[0483]
[0484] Comparison = Comparison Examples / References
[0485] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Phase C was added and the mixture was cooled to room temperature with stirring.
[0486] The SPF of the two formulations was tested in vitro and in vivo. The results are shown in Table 5.2 below:
[0487] Table 5.2
[0488]
[0489] The results showed that the formulation of the present invention (the present invention 5) had a significantly increased SPF compared to the same composition (Comparative 5) which did not contain the wax compounds of the present invention.
[0490] Example 6
[0491] Table 6.1: Test Preparations
[0492]
[0493] Comparison = Comparison Examples / References
[0494] qs = Amount required to dissolve PBSA
[0495] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Pre-mixed phase C was added, and the mixture was cooled to room temperature with stirring.
[0496] The SPF of all formulations was tested in vitro and in vivo. The results are shown in Table 6.2 below:
[0497] Table 6.2
[0498]
[0499] The results showed that the formulations of the present invention (6.1 and 6.2 of the present invention) had a significantly increased SPF compared to the same compositions (Comparative 6) that did not contain the wax compounds of the present invention.
[0500] Example 7
[0501] Table 7.1: Test Preparations
[0502]
[0503] Comparison = Comparison Examples / References
[0504] qs = The amount required to adjust the desired pH
[0505] The active amount of TDSA in Uvinul® TS Hydro is 33%.
[0506] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring and homogenized using an Ultra Turrax apparatus. Pre-mixed phase C was added, and the mixture was cooled to room temperature with stirring.
[0507] The SPF of the two formulations were tested in vitro. The results are shown in Table 7.2 below:
[0508] Table 7.2
[0509]
[0510] The results showed that the formulation of the present invention (the present invention 7) had a significantly increased SPF compared to the same composition (Comparative 7) which did not contain the wax compounds of the present invention.
[0511] Example 8
[0512] Table 8.1: Test Preparations
[0513]
[0514] Table 8.2: Test Preparations
[0515]
[0516] Comparison = Comparison Examples / References
[0517] The composition was prepared as follows: Phases A and B were heated to 80°C with stirring. Phase A was added to B with stirring, homogenized using an Ultra Turrax apparatus, and cooled to room temperature with stirring.
[0518] The SPF of all formulations was tested in vitro. The results are shown in Table 8.3 below:
[0519] Table 8.3
[0520]
[0521] The results showed that the addition of disoprocoyl pentaerythritol distearate citrate increased SPF, as determined in in vitro tests for all tested organic UV filters. The increase in BEMT was found to be the most significant. Even with UVA filters such as BMDBM and DHHB, the SPF could be unexpectedly increased.
Claims
1. A sunscreen or daily care composition comprising: (i) a amount of 0.5 to 8.0 wt.% of the total weight of the composition, comprising pentaerythritol distearate citrate; and (ii) At least one organic UV filter, selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl dicamphor sulfonic acid (TDSA), ethylhexyl triazine ketone (EHT), diethylhexyl butamidotriazine ketone (DBT), phenyl benzimidazole sulfonic acid (PBSA), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), cresoltrazolium trisiloxane (DTS), phenyl bis-diphenyl triazine (PBDT), polysiloxane-15 (PS-15), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof, in an amount of 1.5 to 40.0 wt.- based on the total weight of the composition.
2. The sunscreen or daily care composition according to claim 1, wherein, Dicocoyl pentaerythritol distearate citrate is included in the composition in an amount of about 1.0 to 6.0 wt.-%, preferably about 2.0 to 5.0 wt.-%, based on the total weight of the composition.
3. The sunscreen or daily care composition according to claim 1 or 2, wherein, The composition comprises at least one UV filter in an amount of 4.0 to 40.0 wt.-%, preferably 5.0 to 35.0 wt.-%, more preferably 6.0 to 35.0 wt.-%, or 7.0 to 30.0 wt.-%, even more preferably 8.0 to 25.0 wt.-%, and particularly 9.0 to 20.0 wt.-%, based on the total weight of the composition.
4. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition contains at least one UVA filter, preferably selected from the group consisting of: disodium phenyl dibenzimidazole tetrasulfonate (DPDT), hexyl diethylaminohydroxybenzoylbenzoate (DHHB), butyl methoxydibenzoylmethane (BMDBM), dimethyl camphor sulfonic acid (TDSA), methoxypropylaminocyclohexene ethoxyethyl cyanoacetate (MCE), and combinations thereof.
5. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition contains at least one UVB filter, preferably selected from the group consisting of ethylhexyl triazine ketone (EHT), diethylhexylbutamidotriazine ketone (DBT), phenylbenzimidazole sulfonic acid (PBSA), and combinations thereof.
6. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition comprises at least one broadband UV filter, preferably selected from the group consisting of: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), cresoltrazol trisiloxane (DTS), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), phenyl bis-diphenyltriazine (PBDT), and combinations thereof.
7. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition comprises at least one organic particulate UV filter selected from the group consisting of: methylene bis-benzotriazolyltetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), bis-(diethylaminohydroxybenzoylbenzoyl)piperazine (BDBP), phenyl bis-diphenyltriazine (PBDT), micronized 1,4-bis(benzoxazol-2'-yl)benzene, and combinations thereof.
8. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition further comprises at least one inorganic UV filter, preferably selected from the group consisting of titanium dioxide, zinc oxide, iron oxide, cerium oxide, and mixtures thereof.
9. The sunscreen or daily care composition according to any one of the preceding claims, wherein, (1) The composition comprises at least one UV filter selected from bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), diethylaminohydroxybenzoylhexylbenzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), phenylbenzimidazole sulfonic acid (PBSA), butyl methoxydibenzoylmethane (BMDBM), terephthalic dimethylene camphor sulfonic acid (TDSA), and any combination of two or more thereof; or (2) The composition comprises bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and one or more of the following: diethylaminohydroxybenzoylhexylbenzoate (DHHB), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyltriazine (TBPT), butyl methoxydibenzoylmethane (BMDBM), terephthaloyl dicamphor sulfonic acid (TDSA), and phenylbenzimidazole sulfonic acid (PBSA); or (3) The composition comprises diethylaminohydroxybenzoylhexyl benzoate (DHHB) and one or more of the following: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), ethylhexyl triazine ketone (EHT), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), butyl methoxydibenzoylmethane (BMDBM), terephthaloyl dicamphor sulfonic acid (TDSA), and phenylbenzimidazole sulfonic acid (PBSA); or (4) The composition comprises ethylhexyl triazine ketone (EHT) and one or more of the following: bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), diethylaminohydroxybenzoylhexyl benzoate (DHHB), methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT), tri-biphenyl triazine (TBPT), butyl methoxydibenzoylmethane (BMDBM), terephthaloyl dicamphor sulfonic acid (TDSA), and phenylbenzimidazole sulfonic acid (PBSA); or (5) The composition comprises ethylhexyl triazine ketone (EHT), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), and diethylaminohydroxybenzoylhexyl benzoate (DHHB).
10. The sun protection or daily care composition according to any one of the preceding claims, wherein the sun protection or daily care composition comprises at least one broadband UV filter, preferably BEMT, preferably in an amount of 0.5 to 10 wt. based on the total weight of the composition.
11. The sunscreen or daily care composition according to any one of the preceding claims, wherein, (1) The composition is free from at least one or more of fluorinated organic compounds, microplastics, and parabens; and / or (2) The composition does not contain any of the following: ethylhexyl methoxycinnamate (EHMC), benzophenone-3 (BP-3), and benzophenone-4 (BP-4).
12. The sunscreen or daily care composition according to any one of the preceding claims, wherein, The composition further comprises at least one additive, preferably selected from the group consisting of: emulsifiers, emollients, viscosity modifiers (thickeners), stabilizers, humectants, film-forming agents, UV scattering compounds, UV enhancers, pH adjusters, sensory enhancers, adjuvants, preservatives, vitamins, fragrances, and combinations thereof.
13. The use of dicocoyl pentaerythritol distearate citrate for improving the sun protection factor of sunscreen or daily care compositions containing at least one UV filter.
14. The use according to claim 13, wherein, Compared to the same composition without dicocoyl pentaerythritol distearate citrate, the SPF is increased by at least 10%, at least 20%, and preferably at least 30%.
15. The use according to claim 13, wherein, Compared to the same composition which does not contain pentaerythritol distearate citrate, but optionally contains hydrogenated coconut oil glyceride, hydrogenated castor oil or lauryl laurate, the water resistance is increased by at least 20%, preferably at least 50%.
Citation Information
Patent Citations
Sunscreen compositions
WO1997003643A1
Sunscreen compositions comprising colour pigmens
WO2009077356A2
Mixtures of cosmetic UV absorbers
WO2015155158A1
Sunscreen or daily care composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine and inorganic UV filters
WO2023036749A1